-
901
-
902
-
903
-
904
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas...
Published 2025-01-01“…Methods Adult patients with mIDH1 R132 AML received 150 mg olutasidenib twice daily plus standard-of-care azacitidine (OLU + AZA) and were evaluated for response and safety. …”
Get full text
Article -
905
-
906
Association between vascular endothelial growth factor and atrial fibrillation: a systematic review
Published 2025-01-01Get full text
Article -
907
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Published 2024-03-01Get full text
Article -
908
-
909
Researching COVID to enhance recovery (RECOVER) pediatric study protocol: Rationale, objectives and design.
Published 2024-01-01Get full text
Article -
910
-
911
-
912
International Society of Sports Nutrition Position Stand: Long-Chain Omega-3 Polyunsaturated Fatty Acids
Published 2025-12-01Get full text
Article -
913
-
914
-
915
-
916
Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
Published 2024-01-01Get full text
Article -
917
-
918
-
919
-
920
The association between salivary oxytocin, age, and puberty in children with and without OCD
Published 2024-11-01Get full text
Article